Device and method for restoration of the condition of blood

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9669150
SERIAL NO

14156255

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a device for extracorporeal removal of harmful agents from blood or blood com-Components, comprising full length heparin immobilized on a solid substrate by covalent end point attachment. The present invention also relates to a method for extracorporeal removal of a harmful agent from mammalian blood or blood components. The present invention further relates to a process for covalent end point attachment of full length heparin to a solid substrate.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
EXTHERA MEDICAL CORPORATION813 HEINZ AVENUE BERKELEY CA 94710

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Adolfsson, Lars Uppsala, SE 18 314
Axelsson, Jonas Stockholm, SE 10 65
Bergstrom, Tomas Gothenburg, SE 8 138
Larm, Olle Bromma, SE 29 943
McCrae, Keith Concord, US 3 17
Ward, Robert S Orinda, US 53 3485

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 6, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00